Showing results (91-100 of 199) with videos related to
Sort By:
Pageof 20
Molecular Diversity|June 24, 2021
Discovery of ( ±)-3-(1H-pyrazol-1-yl)-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activityParameshwara Chary Jilloju, Leentje Persoons, Sathish Kumar Kurapati, et al.Optics Express|December 25, 2012
Investigation of spectrally shaped DFTS-OFDM for long haul transmissionSusmita Adhikari, Sander Jansen, Maxim Kuschnerov, et al.Nature Communications|November 14, 2015
Sialic acid-dependent cell entry of human enterovirus D68Yue Liu, Ju Sheng, Jim Baggen, et al.Bioorganic & Medicinal Chemistry|March 22, 2018
The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2Xueyi Lu, Jiapei Yang, Dongwei Kang, et al.Molecules (Basel, Switzerland)|January 8, 2023
Biological Activity of Amidino-Substituted Imidazo [4,5-<i>b</i>]pyridinesIda Boček Pavlinac, Katarina Zlatić, Leentje Persoons, et al.Journal of Medicinal Chemistry|December 5, 2009
A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replicationSerena Massari, Dirk Daelemans, Maria Letizia Barreca, et al.Journal of Virology|October 20, 2006
Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virusJan Balzarini, Kristel Van Laethem, Dirk Daelemans, et al.Chemical Biology & Drug Design|February 26, 2016
Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism ApproachXiao Li, Boshi Huang, Zhongxia Zhou, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of ChalconesMarta Gargantilla, José López-Fernández, Maria-Jose Camarasa, et al.Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear exportDirk Daelemans, Elena Afonina, Jakob Nilsson, et al.Pageof 20